205 related articles for article (PubMed ID: 7758129)
41. Effect of prostaglandin E2 (PGE2) on IL-3/granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2.
Li TK; Fox BS
J Immunol; 1993 Mar; 150(5):1680-90. PubMed ID: 8436811
[TBL] [Abstract][Full Text] [Related]
42. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
43. Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes.
Kass E; Parker J; Schlom J; Greiner JW
Cytokine; 2000 Jul; 12(7):960-71. PubMed ID: 10880241
[TBL] [Abstract][Full Text] [Related]
44. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.
Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R
Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908
[TBL] [Abstract][Full Text] [Related]
45. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation.
Scheicher C; Mehlig M; Dienes HP; Reske K
Eur J Immunol; 1995 Jun; 25(6):1566-72. PubMed ID: 7614984
[TBL] [Abstract][Full Text] [Related]
46. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols.
Frosch S; Bonifas U; Eck HP; Bockstette M; Droege W; Rüde E; Reske-Kunz AB
Eur J Immunol; 1993 Jul; 23(7):1430-4. PubMed ID: 8325319
[TBL] [Abstract][Full Text] [Related]
47. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma.
Koch N; Wong GH; Schrader JW
J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464
[TBL] [Abstract][Full Text] [Related]
48. Cyclosporine and FK506 inhibition of murine mast cell cytokine production.
Hatfield SM; Roehm NW
J Pharmacol Exp Ther; 1992 Feb; 260(2):680-8. PubMed ID: 1371158
[TBL] [Abstract][Full Text] [Related]
49. Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors.
Yung YP; Wang SY; Moore MA
J Immunol; 1983 Jun; 130(6):2843-8. PubMed ID: 6602184
[TBL] [Abstract][Full Text] [Related]
50. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4.
Hültner L; Moeller J; Schmitt E; Jäger G; Reisbach G; Ring J; Dörmer P
J Immunol; 1989 May; 142(10):3440-6. PubMed ID: 2785556
[TBL] [Abstract][Full Text] [Related]
51. Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1).
Stuart PM; Zlotnik A; Woodward JG
J Immunol; 1988 Mar; 140(5):1542-7. PubMed ID: 2450129
[TBL] [Abstract][Full Text] [Related]
52. Effects of transforming growth factor-beta on bone marrow macrophage Ia expression induced by cytokines.
Gollnick SO; Cheng HL; Grande CC; Thompson D; Tomasi TB
J Interferon Cytokine Res; 1995 May; 15(5):485-91. PubMed ID: 7648451
[TBL] [Abstract][Full Text] [Related]
53. Induction of IL-4 release and upregulated expression of protease activated receptors by GM-CSF in P815 cells.
Zhang H; Yang H; Zhang L; Yang X; Zhang Z; Lin Q; He S
Cytokine; 2009 Dec; 48(3):196-202. PubMed ID: 19651524
[TBL] [Abstract][Full Text] [Related]
54. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation.
Wodnar-Filipowicz A; Heusser CH; Moroni C
Nature; 1989 May; 339(6220):150-2. PubMed ID: 2524008
[TBL] [Abstract][Full Text] [Related]
55. FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells.
Tkaczyk C; Villa I; Peronet R; David B; Mécheri S
Immunology; 1999 Jun; 97(2):333-40. PubMed ID: 10447750
[TBL] [Abstract][Full Text] [Related]
56. Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor.
McAdam AJ; Pulaski BA; Storozynsky E; Yeh KY; Sickel JZ; Frelinger JG; Lord EM
Cell Immunol; 1995 Oct; 165(2):183-92. PubMed ID: 7553882
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
[TBL] [Abstract][Full Text] [Related]
58. Modulation of the Fc gamma RII and Fc gamma RIII induced by GM-CSF, IFN-gamma and IL-4 on murine eosinophils.
de Andrés B; Cárdaba B; del Pozo V; Martín-Orozco E; Gallardo S; Tramón P; Palomino P; Lahoz C
Immunology; 1994 Sep; 83(1):155-60. PubMed ID: 7529744
[TBL] [Abstract][Full Text] [Related]
59. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction.
Razin E; Leslie KB; Schrader JW
J Immunol; 1991 Feb; 146(3):981-7. PubMed ID: 1824852
[TBL] [Abstract][Full Text] [Related]
60. The mast cell-committed progenitor. In vitro generation of committed progenitors from bone marrow.
Ashman RI; Jarboe DL; Conrad DH; Huff TF
J Immunol; 1991 Jan; 146(1):211-6. PubMed ID: 1898599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
